Literature DB >> 24082369

Feasibility of temporary biventricular pacing after off-pump coronary artery bypass grafting in patients with reduced left ventricular function.

Daniel Y Wang1, Lauren A Kelly, Marc E Richmond, T Alexander Quinn, Bin Cheng, Michelle D Spotnitz, Santos E Cabreriza, Yoshifumi Naka, Allan S Stewart, Craig R Smith, Henry M Spotnitz.   

Abstract

In selected patients undergoing cardiac surgery, our research group previously showed that optimized temporary biventricular pacing can increase cardiac output one hour after weaning from cardiopulmonary bypass. Whether pacing is effective after beating-heart surgery is unknown. Accordingly, in this study we examined the feasibility of temporary biventricular pacing after off-pump coronary artery bypass grafting. The effects of optimized pacing on cardiac output were measured with an electromagnetic aortic flow probe at the conclusion of surgery in 5 patients with a preoperative mean left ventricular ejection fraction of 0.26 (range, 0.15-0.35). Atrioventricular (7) and interventricular (9) delay settings were optimized in randomized order. Cardiac output with optimized biventricular pacing was 4.2 ± 0.7 L/min; in sinus rhythm, it was 3.8 ± 0.5 L/min. Atrial pacing at a matched heart rate resulted in cardiac output intermediate to that of sinus rhythm and biventricular pacing (4 ± 0.6 L/min). Optimization of atrioventricular and interventricular delay, in comparison with nominal settings, trended toward increased flow. This study shows that temporary biventricular pacing is feasible in patients with preoperative left ventricular dysfunction who are undergoing off-pump coronary artery bypass grafting. Further study of the possible clinical benefits of this intervention is warranted.

Entities:  

Keywords:  Arrhythmias, cardiac/therapy; cardiac output, low/therapy; cardiac pacing, artificial/methods; heart failure/therapy; stroke volume; ventricular dysfunction, left/complications/prevention & control

Mesh:

Year:  2013        PMID: 24082369      PMCID: PMC3783126     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  44 in total

1.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

2.  Temporary left ventricular pacing improves haemodynamic performance in patients requiring epicardial pacing post cardiac surgery.

Authors:  Michael J Flynn; Janet M McComb; John Henry Dark
Journal:  Eur J Cardiothorac Surg       Date:  2005-08       Impact factor: 4.191

3.  Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT.

Authors:  R J van Bommel; J Gorcsan; E S Chung; W T Abraham; F T Gjestvang; C Leclercq; M J Monaghan; P Nihoyannopoulos; C Peraldo; C-M Yu; M Demas; B Gerritse; J J Bax
Journal:  Heart       Date:  2010-07       Impact factor: 5.994

4.  Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy.

Authors:  Eugene S Chung; Rodolphe P Katra; Stefano Ghio; Jeroen Bax; Bart Gerritse; Kathryn Hilpisch; Brett J Peterson; David S Feldman; William T Abraham
Journal:  Eur J Heart Fail       Date:  2010-02-11       Impact factor: 15.534

5.  Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping.

Authors:  Radu Vatasescu; Antonio Berruezo; Lluis Mont; David Tamborero; Marta Sitges; Etel Silva; Jose María Tolosana; Bárbara Vidal; David Andreu; Josep Brugada
Journal:  Europace       Date:  2009-10-31       Impact factor: 5.214

6.  The effect of biventricular pacing on cardiac function after weaning from cardiopulmonary bypass in patients with reduced left ventricular function: a pressure-volume loop analysis.

Authors:  Thorsten Hanke; Martin Misfeld; Matthias Heringlake; Jan J Schreuder; Uwe K H Wiegand; Frank Eberhardt
Journal:  J Thorac Cardiovasc Surg       Date:  2009-04-08       Impact factor: 5.209

7.  Impact of atrio-biventricular pacing to poor left-ventricular function after CABG.

Authors:  U Weisse; F Isgro; Ch Werling; A Lehmann; W Saggau
Journal:  Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 1.827

8.  Temporary biventricular pacing postcardiopulmonary bypass in patients with reduced ejection fraction.

Authors:  Jochen D Muehlschlegel; Yong G Peng; Emilio B Lobato; Philip J Hess; Tomas D Martin; Charles T Klodell
Journal:  J Card Surg       Date:  2008 Jul-Aug       Impact factor: 1.620

9.  Response of mean arterial pressure to temporary biventricular pacing after chest closure during cardiac surgery.

Authors:  Benjamin J Rubinstein; Daniel Y Wang; Santos E Cabreriza; Bin Cheng; Linda Aponte-Patel; Alexandra Murata; Alexander Rusanov; Marc E Richmond; T Alexander Quinn; Henry M Spotnitz
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-21       Impact factor: 5.209

10.  Acute hemodynamic effects of atrio-biventricular pacing in humans.

Authors:  A H Foster; M R Gold; J S McLaughlin
Journal:  Ann Thorac Surg       Date:  1995-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.